Plus, news about Tectonic Therapeutic, Molecular Partners and Arcus Biosciences:
EnGene snags $60M: The Boston and Montreal gene therapy biotech
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The benefit-harm balance of initiating Glucagon-like Peptide-1 (GLP-1) receptor agonists (RAs) versus a placebo intervention.
Whether micro- and nano-plastics (MNPs) are detectable in atherosclerotic plaques.
As molecular biologists at Boston University and as husband and wife, Ruslan Afasizhev and Inna Afasizheva, have worked together for decades. Together, they have published